- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
-
- 长期趋势：
已有108家主力机构披露2024-06-30报告期持股数据，持仓量总计2.11亿股，占流通A股65.39%
- 波段诊断：
-
技术面诊股
诊断结果：2.0技术面打败了3%的股票
技术面评分前10的股票
近期的平均成本为38.18元。
平均成本
近期的平均成本为38.18元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"38.18","date":1732091300,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，明显跑输行业平均水平。
[{"date":"2024.11.21","stock":"-1.68","trade":"0.22","ind":"0.07"},{"date":"2024.11.20","stock":"0.47","trade":"2.52","ind":"0.66"},{"date":"2024.11.19","stock":"1.42","trade":"2.19","ind":"0.67"},{"date":"2024.11.18","stock":"-0.94","trade":"-2.07","ind":"-0.21"},{"date":"2024.11.15","stock":"-1.62","trade":"-2.51","ind":"-1.45"},{"date":"2024.11.14","stock":"-3.04","trade":"-3.03","ind":"-1.73"},{"date":"2024.11.13","stock":"-1.35","trade":"-1.31","ind":"0.51"},{"date":"2024.11.12","stock":"1.04","trade":"0.55","ind":"-1.39"},{"date":"2024.11.11","stock":"0.37","trade":"2.28","ind":"0.51"},{"date":"2024.11.08","stock":"-0.15","trade":"-0.32","ind":"-0.53"},{"date":"2024.11.07","stock":"2.94","trade":"2.56","ind":"2.57"},{"date":"2024.11.06","stock":"0.03","trade":"-0.13","ind":"-0.09"},{"date":"2024.11.05","stock":"0.96","trade":"2.58","ind":"2.32"},{"date":"2024.11.04","stock":"2.17","trade":"1.73","ind":"1.17"},{"date":"2024.11.01","stock":"0.32","trade":"-1.43","ind":"-0.24"},{"date":"2024.10.31","stock":"-0.24","trade":"0.45","ind":"0.42"},{"date":"2024.10.30","stock":"-2.58","trade":"-1.33","ind":"-0.61"},{"date":"2024.10.29","stock":"-2.46","trade":"-3.08","ind":"-1.08"},{"date":"2024.10.28","stock":"-0.75","trade":"1.23","ind":"0.68"},{"date":"2024.10.25","stock":"0.70","trade":"1.14","ind":"0.59"},{"date":"2024.10.24","stock":"0.76","trade":"1.77","ind":"-0.68"}]
西藏药业,上证指数,生物制品指数
压力支撑
该股压力位为38.07元，支撑位为37.52元。
[{"text":"\u538b\u529b\u4f4d","value":"38.07","date":1732118400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"37.52","date":1732118400,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.0资金面打败了24%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：11月21日 17:14
| 机构今日流向(万元) | -2566.03 | 机构5日流向(万元) | -5593.51 |
| 机构10日流向(万元) | -12534.28 | 机构20日流向(万元) | -16200.99 |
机构持仓
2024-06-30 与 2023-12-31 相比，主力机构持仓量增加4436.54万股，其中基金净增仓33家，主力净减仓49家，请投资者中长期谨慎为宜。
截止2024-06-30，共108家主力机构（基金97家，QFII1家，一般法人7家，社保基金1家，券商集合理财2家），持仓量总计21076.37万股，占流通A股65.39%
其中，基金持仓与2023-12-31相比：
增仓：47家 ，增持 425.45万股
减仓：14家 ，减持 55.45万股
新出现在主力名单中：38家 ，持有350.99万股
从主力名单中消失：87家 ，原持有744.84万股
其中，基金持仓与2023-12-31相比：
增仓：47家 ，增持 425.45万股
减仓：14家 ，减持 55.45万股
新出现在主力名单中：38家 ，持有350.99万股
从主力名单中消失：87家 ，原持有744.84万股
消息面诊股
诊断结果：6消息面打败了94%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 西藏药业：11月20日获融资买入1266.69万元
2024-11-21 - 西藏药业：11月19日获融资买入759.78万元，
2024-11-20 - 西藏药业：新活素扩建生产线的制剂车间已通过GMP符
2024-11-19 - 行业追踪|中医药市场（11月11日-11月17日）
2024-11-17 - 西藏药业：11月13日融券卖出金额2.41万元，占
2024-11-14 - 西藏药业：11月12日获融资买入3780.25万元
2024-11-13 - 西藏药业：11月11日获融资买入2767.12万元
2024-11-12 - 西藏药业：11月8日融券卖出金额2.81万元，占当
2024-11-11 - 行业追踪|中医药市场（11月4日-11月10日）：
2024-11-10 - 西藏药业：11月7日获融资买入4265.97万元，
2024-11-08
消息列表
| 一般消息 | 募资投向 | 公司购买资产 | 2024-10-31 |
| 利好 | 分红转增 | 10派9.67元(含税) | 2024-08-14 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-06-30 |
| 一般消息 | 重大事项 | 关联交易 | 2024-04-17 |
| 一般消息 | 股东大会 | 年度股东大会 | 2024-03-27 |
| 利好 | 分红转增 | 10转3股派7.37元(含税) | 2024-03-27 |
| 一般消息 | 重大事项 | 关联交易 | 2024-03-27 |
| 一般消息 | 高管变动 | 突发疾病不幸去世 | 2024-03-06 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2024-01-19 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2023-12-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2023-12-29 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 5条 | 1条 | 4条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.5行业面打败了82%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2024.11.21","price":"0.07","value":"0.22"},{"date":"2024.11.20","price":"0.66","value":"2.52"},{"date":"2024.11.19","price":"0.67","value":"2.19"},{"date":"2024.11.18","price":"-0.21","value":"-2.07"},{"date":"2024.11.15","price":"-1.45","value":"-2.51"},{"date":"2024.11.14","price":"-1.73","value":"-3.03"},{"date":"2024.11.13","price":"0.51","value":"-1.31"},{"date":"2024.11.12","price":"-1.39","value":"0.55"},{"date":"2024.11.11","price":"0.51","value":"2.28"},{"date":"2024.11.08","price":"-0.53","value":"-0.32"},{"date":"2024.11.07","price":"2.57","value":"2.56"},{"date":"2024.11.06","price":"-0.09","value":"-0.13"},{"date":"2024.11.05","price":"2.32","value":"2.58"},{"date":"2024.11.04","price":"1.17","value":"1.73"},{"date":"2024.11.01","price":"-0.24","value":"-1.43"},{"date":"2024.10.31","price":"0.42","value":"0.45"},{"date":"2024.10.30","price":"-0.61","value":"-1.33"},{"date":"2024.10.29","price":"-1.08","value":"-3.08"},{"date":"2024.10.28","price":"0.68","value":"1.23"},{"date":"2024.10.25","price":"0.59","value":"1.14"},{"date":"2024.10.24","price":"-0.68","value":"1.77"}]
上证指数,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 四环生物 | 32.03% | 8.68% | 6.0分 |
| 2 | 荣昌生物 | 23.52% | 9.71% | 5.8分 |
| 3 | 康希诺 | 19.86% | -0.59% | 4.9分 |
| 4 | 百普赛斯 | 14.81% | 1.20% | 5.2分 |
| 5 | 金迪克 | 12.35% | -3.07% | 4.5分 |
| 6 | 万泽股份 | 12.12% | 4.55% | 6.6分 |
| 8 | 长春高新 | 9.92% | 0.92% | 5.2分 |
| 10 | 辽宁成大 | 6.87% | 0.68% | 4.3分 |
| 12 | 康辰药业 | 5.77% | 2.30% | 5.5分 |
| 14 | 诺唯赞 | 5.30% | -3.21% | 5.1分 |
| 16 | 优宁维 | 4.70% | -0.09% | 5.7分 |
| 18 | 通化东宝 | 3.95% | -0.46% | 4.6分 |
| 20 | 东宝生物 | 2.78% | 2.59% | 5.7分 |
| 22 | 成大生物 | 2.06% | 0.04% | 4.5分 |
| 24 | 诺诚健华 | 1.33% | 6.70% | 5.0分 |
| 26 | 华兰疫苗 | 1.00% | 0.30% | 5.8分 |
| 28 | 迈威生物 | -0.33% | -2.73% | 5.0分 |
| 30 | 天坛生物 | -0.72% | -0.72% | 5.3分 |
| 32 | 康弘药业 | -1.43% | 2.45% | 6.5分 |
| 34 | 沃森生物 | -2.61% | -3.59% | 5.0分 |
| 36 | 赛伦生物 | -2.62% | -2.24% | 4.2分 |
| 38 | 安科生物 | -2.67% | -2.57% | 5.0分 |
| 40 | 万泰生物 | -3.25% | 0.24% | 5.2分 |
| 42 | 君实生物 | -4.30% | 0.26% | 4.7分 |
| 44 | 智翔金泰 | -4.77% | -2.34% | 3.7分 |
| 46 | 我武生物 | -6.69% | -3.36% | 4.8分 |
| 48 | 百克生物 | -7.88% | -2.65% | 4.9分 |
| 50 | 甘李药业 | -9.56% | -0.81% | 4.6分 |
| 52 | 特宝生物 | -10.24% | -2.16% | 4.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：很强，居行业前列，两项指标的行业排名分别为 2/73 ， 3/73。
[{"date":"2024-09-30","value":"22.71","vol":"1.38"},{"date":"2024-06-30","value":"17.46","vol":"0.75"},{"date":"2024-03-31","value":"8.94","vol":"0.43"},{"date":"2023-12-31","value":"25.20","vol":"1.90"},{"date":"2023-09-30","value":"26.60","vol":"3.06"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
22.71 | 17.46 | 8.94 | 25.20 | 26.60 |
| 行业(%) | 1.38 | 0.75 | 0.43 | 1.90 | 3.06 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"94.93","vol":"70.59"},{"date":"2024-06-30","value":"95.70","vol":"69.95"},{"date":"2024-03-31","value":"94.83","vol":"70.47"},{"date":"2023-12-31","value":"95.05","vol":"69.93"},{"date":"2023-09-30","value":"95.34","vol":"69.71"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
94.93 | 95.70 | 94.83 | 95.05 | 95.34 |
| 行业(%) | 70.59 | 69.95 | 70.47 | 69.93 | 69.71 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，两项指标的行业排名分别为 35/73 ， 28/73。
[{"date":"2024-09-30","value":"-8.13","vol":"173.80"},{"date":"2024-06-30","value":"-11.29","vol":"17.95"},{"date":"2024-03-31","value":"-22.35","vol":"29.19"},{"date":"2023-12-31","value":"22.69","vol":"18.84"},{"date":"2023-09-30","value":"20.93","vol":"15.35"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-8.13 | -11.29 | -22.35 | 22.69 | 20.93 |
| 行业(%) | 173.80 | 17.95 | 29.19 | 18.84 | 15.35 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"-7.42","vol":"-54.20"},{"date":"2024-06-30","value":"4.57","vol":"-10.79"},{"date":"2024-03-31","value":"3.21","vol":"-528.49"},{"date":"2023-12-31","value":"116.56","vol":"-34.06"},{"date":"2023-09-30","value":"93.17","vol":"272.44"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-7.42 | 4.57 | 3.21 | 116.56 | 93.17 |
| 行业(%) | -54.20 | -10.79 | -528.49 | -34.06 | 272.44 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，居行业前列，两项指标的行业排名分别为 3/73 ， 17/73。
[{"date":"2024-09-30","value":"0.47","vol":"0.22"},{"date":"2024-06-30","value":"0.33","vol":"0.14"},{"date":"2024-03-31","value":"0.15","vol":"0.07"},{"date":"2023-12-31","value":"0.72","vol":"0.33"},{"date":"2023-09-30","value":"0.54","vol":"0.24"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.47 | 0.33 | 0.15 | 0.72 | 0.54 |
| 行业(次) | 0.22 | 0.14 | 0.07 | 0.33 | 0.24 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.89","vol":"0.87"},{"date":"2024-06-30","value":"0.58","vol":"0.55"},{"date":"2024-03-31","value":"0.33","vol":"0.26"},{"date":"2023-12-31","value":"1.47","vol":"1.31"},{"date":"2023-09-30","value":"1.02","vol":"0.93"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.89 | 0.58 | 0.33 | 1.47 | 1.02 |
| 行业(次) | 0.87 | 0.55 | 0.26 | 1.31 | 0.93 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"27.20","vol":"-28.68"},{"date":"2024-06-30","value":"17.41","vol":"-36165.87"},{"date":"2024-03-31","value":"61.94","vol":"-43943.29"},{"date":"2023-12-31","value":"36.56","vol":"-170.97"},{"date":"2023-09-30","value":"43.53","vol":"-29016.32"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 27.20 | 17.41 | 61.94 | 36.56 | 43.53 |
| 行业 | -28.68 | -36165.87 | -43943.29 | -170.97 | -29016.32 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.28","vol":"2.73"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"0.31","vol":"2.86"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.28 | - | 0.31 | - |
| 行业 | 0.00 | 2.73 | 0.00 | 2.86 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 25/73 ， 33/73。
[{"date":"2024-09-30","value":"3.58","vol":"7.11"},{"date":"2024-06-30","value":"2.80","vol":"6.99"},{"date":"2024-03-31","value":"2.87","vol":"8.01"},{"date":"2023-12-31","value":"2.87","vol":"7.53"},{"date":"2023-09-30","value":"2.72","vol":"8.24"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
3.58 | 2.80 | 2.87 | 2.87 | 2.72 |
| 行业 | 7.11 | 6.99 | 8.01 | 7.53 | 8.24 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"3.34","vol":"5.73"},{"date":"2024-06-30","value":"2.65","vol":"5.87"},{"date":"2024-03-31","value":"2.75","vol":"6.87"},{"date":"2023-12-31","value":"2.74","vol":"6.45"},{"date":"2023-09-30","value":"2.58","vol":"7.25"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
3.34 | 2.65 | 2.75 | 2.74 | 2.58 |
| 行业 | 5.73 | 5.87 | 6.87 | 6.45 | 7.25 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 22/73 ， 22/73。
[{"date":"2024-09-30","value":"21.57","vol":"24.72"},{"date":"2024-06-30","value":"28.31","vol":"24.44"},{"date":"2024-03-31","value":"27.46","vol":"23.84"},{"date":"2023-12-31","value":"26.46","vol":"23.96"},{"date":"2023-09-30","value":"27.01","vol":"22.75"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
21.57 | 28.31 | 27.46 | 26.46 | 27.01 |
| 行业(%) | 24.72 | 24.44 | 23.84 | 23.96 | 22.75 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.28","vol":"0.40"},{"date":"2024-06-30","value":"0.40","vol":"0.38"},{"date":"2024-03-31","value":"0.38","vol":"0.36"},{"date":"2023-12-31","value":"0.36","vol":"0.35"},{"date":"2023-09-30","value":"0.37","vol":"0.32"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.28 | 0.40 | 0.38 | 0.36 | 0.37 |
| 行业(%) | 0.40 | 0.38 | 0.36 | 0.35 | 0.32 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2024年每股收益与前一年相同，长期投资价值一般。
[{"date":"2020","yellowRectValue":"4.18","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"2.09","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"3.70","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"8.01","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"10.64","blueLineValue":"3.55","type":"YC"}]